{
    "title": "Samsung BioLogics says mass producing Eli Lilly's COVID-19 treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8956243/Samsung-BioLogics-says-mass-producing-Eli-Lillys-COVID-19-treatment.html",
    "date": "2020-11-17",
    "keywords": [
        "drug",
        "covid19",
        "antibody",
        "fda",
        "month",
        "risk",
        "manufacturing",
        "seoul",
        "ltd",
        "tuesday",
        "treatment",
        "week",
        "emergencyuse",
        "approval",
        "food",
        "administration",
        "bamlanivimab",
        "need",
        "hospitalisation",
        "emergency",
        "room",
        "disease",
        "progression",
        "mildtomoderate",
        "health",
        "illness",
        "end",
        "use",
        "worldwide",
        "year",
        "supply",
        "quarter",
        "samsung",
        "contract",
        "firm",
        "technology",
        "transfer",
        "process",
        "production",
        "deal",
        "class",
        "biotech",
        "case",
        "copy",
        "body",
        "infection",
        "regeneron",
        "president",
        "trump",
        "diagnosis",
        "reporting",
        "joyce",
        "lee",
        "jacqueline",
        "wong",
        "christopher",
        "cushing"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}